Rasburicase and Tumor Lysis Syndrome: Lower Dosage, Consideration of Indications, and Hyperhydration

被引：17
|
作者：
Darmon, Michael [1 ]
Guichard, Isabelle [1 ]
Vincent, Francois [2 ]
机构：
[1] St Etienne Teaching Hosp, St Etienne, France
[2] Avicenne Teaching Hosp, Bobigny, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 03期
关键词：
SINGLE-DOSE RASBURICASE; 6; MG; ADULTS; HYPERURICEMIA; PROPHYLAXIS; MANAGEMENT; CANCER;
D O I：
10.1200/JCO.2010.32.6751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E67 / E68
页数：2
相关论文
共 50 条
  • [21] Recommendations for the management of tumor lysis syndrome (TLS) with rasburicase:: An observational survey
    Bertrand, Yves
    Mechinaud, Francoise
    Brethon, Benoit
    Mialou, Valerie
    Auvrignon, Anne
    Nelken, Brigitte
    Notz-Carrere, Anne
    Plantaz, Dominique
    Patte, Catherine
    Urbieta, Marisol
    Baruchel, Andre
    Leverger, Guy
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (04) : 267 - 271
  • [22] Role of i.v. allopurinol and rasburicase in tumor lysis syndrome
    Holdsworth, MT
    Ngltyen, P
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (21) : 2213 - 2222
  • [23] Recombinant urate oxidase (rasburicase) in the prophylaxis and treatment of tumor lysis syndrome
    Jeha, S
    Pui, CH
    HYPERURICEMIC SYNDROMES: PATHOPHYSIOLOGY AND THERAPY, 2005, 147 : 69 - 79
  • [24] Rasburicase for Huge Hepatocellular Carcinoma with Tumor Lysis Syndrome: Case Report
    Chao, Chia-Ter
    Chiang, Chih-Kang
    MEDICAL PRINCIPLES AND PRACTICE, 2012, 21 (05) : 498 - 500
  • [25] Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma
    Personett, Heather A.
    Barreto, Erin F.
    McCullough, Kristen B.
    Dierkhising, Ross
    Leung, Nelson
    Habermann, Thomas M.
    LEUKEMIA & LYMPHOMA, 2019, 60 (09) : 2271 - 2277
  • [26] Rasburicase in Tumor Lysis Syndrome of the Adult: A Systematic Review and Meta-analysis
    Lopez-Olivo, Maria A.
    Pratt, Gregory
    Palla, Shana L.
    Salahudeen, Abdulla
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (03) : 481 - 492
  • [27] Impact of Early Rasburicase on Incidence and Outcomes of Clinical Tumor Lysis Syndrome in Lymphoma
    Personett, Heather A.
    Barreto, Erin F.
    McCullough, Kristen
    Dierkhising, Ross
    Leung, Nelson
    Habermann, Thomas M.
    BLOOD, 2018, 132
  • [28] Rasburicase: future directions in tumor lysis management
    Hochberg, Jessica
    Cairo, Mitchell S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (10) : 1595 - 1604
  • [29] Distinct mechanisms for rasburicase induced hemolytic anemia and methemoglobinemia in tumor lysis syndrome
    Rodrigo Lopes da Silva
    International Journal of Clinical Pharmacy, 2011, 33 : 471 - 472
  • [30] Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience
    Takai, Mihoko
    Yamauchi, Takahiro
    Matsuda, Yasufumi
    Tai, Katsunori
    Ikegaya, Satoshi
    Kishi, Shinji
    Urasaki, Yoshimasa
    Yoshida, Akira
    Iwasaki, Hiromichi
    Ueda, Takanori
    ONCOLOGY LETTERS, 2015, 9 (05) : 2119 - 2125
12345